Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Lyophilisation, vial, stopper, certificate of analysis and cold-chain packaging are costs incurred largely per vial rather than per milligram, so cost per milligram of peptide falls as vial content rises
That puts the earliest realistic decision window in late 2027 to the first half of 2028
Alexander Kokkinos Carel Le Roux To view or add a comment, sign in Tirzepatide: Redefining Outcomes in Diabetes & Obesity Care Clinical trials show tirzepatide, a dual GIP/GLP-1 receptor agonist, is delivering results beyond expectations: Up to 20.9% mean weight loss at 72 weeks (SURMOUNT-1, NEJM) 94% risk reduction in progression from prediabetes to type 2 diabetes over 3 years Superior HbA1c reduction and weight control vs leading GLP-1 therapies (SURPASS program) With manageable side effects and durable outcomes, tirzepatide is reshaping how we approach metabolic disease
Ettersprselen er strre enn tilbudet
Although costs of some have gone down recently, branded GLP-1s are typically $499/month and up, if you are paying out of pocket
